GeneReach Biotechnology (4171)

Currency in TWD
20.20
0.00(0.00%)
Closed·
4171 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 12 days
4171 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19.9020.40
52 wk Range
15.4034.90
Key Statistics
Bid/Ask
134.50 / 135.00
Prev. Close
23.1
Open
19.9
Day's Range
19.9-20.4
52 wk Range
15.4-34.9
Volume
50.31K
Average Volume (3m)
249.5K
1-Year Change
-30.46%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4171 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral

GeneReach Biotechnology Company Profile

GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers automatic nucleic acid extraction systems, prep homogenization system, and mini centrifuge equipment; and reagents and consumables, comprising human IVD assays, iiPCR specific reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and research reagents and consumables. It also provides polymerase chain reaction training programs (PCR), molecular diagnostic technical solutions, laboratory installation services, OEM/ODM contract manufacturing services, and research collaboration services. It serves aquaculture, agriculture, food, and human health industries, as well as companion animals and livestock. The company was founded in 2004 and is headquartered in Taichung, Taiwan.

0
Market
Taiwan

Compare 4171 to Peers and Sector

Metrics to compare
4171
Peers
Sector
Relationship
P/E Ratio
−10.7x−206.8x−0.5x
PEG Ratio
−0.40−2.310.00
Price/Book
1.7x6.3x2.6x
Price / LTM Sales
5.4x10.0x3.3x
Upside (Analyst Target)
-0.0%43.5%
Fair Value Upside
Unlock−14.7%6.9%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-0.18 / --
Revenue / Forecast
52.47M / --
EPS Revisions
Last 90 days

4171 Income Statement

FAQ

What Stock Exchange Does GeneReach BioTech Trade On?

GeneReach BioTech is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for GeneReach BioTech?

The stock symbol for GeneReach BioTech is "4171."

What Is the GeneReach BioTech Market Cap?

As of today, GeneReach BioTech market cap is 1.16B.

What Is GeneReach BioTech's Earnings Per Share (TTM)?

The GeneReach BioTech EPS (TTM) is -1.89.

When Is the Next GeneReach BioTech Earnings Date?

GeneReach BioTech will release its next earnings report on 18 Aug 2025.

From a Technical Analysis Perspective, Is 4171 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has GeneReach BioTech Stock Split?

GeneReach BioTech has split 4 times.

How Many Employees Does GeneReach BioTech Have?

GeneReach BioTech has 0 employees.

What is the current trading status of GeneReach BioTech (4171)?

As of 07 Aug 2025, GeneReach BioTech (4171) is trading at a price of 20.20, with a previous close of 23.10. The stock has fluctuated within a day range of 19.90 to 20.40, while its 52-week range spans from 15.40 to 34.90.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.